United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 11:39AM EDT. Market open.
| Previous Close | 272.88 |
| Open | 271.15 |
| Bid | 268.81 x 100 |
| Ask | 269.84 x 100 |
| Day's Range | 268.04 - 274.00 |
| 52 Week Range | 204.44 - 279.98 |
| Volume | |
| Avg. Volume | 530,359 |
| Market Cap | 11.949B |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | 12.75 |
| EPS (TTM) | 21.12 |
| Earnings Date | Jul 31, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 300.95 |
ZacksHere's Why United Therapeutics (UTHR) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ZacksHere's Why United Therapeutics (UTHR) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
GuruFocus.comInsider Sale: CFO and Treasurer James Edgemond Sells 40,160 Shares of United Therapeutics Corp ...
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
© 2024 Yahoo. All rights reserved.